Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert Pinhasov

Showing results (91-100 of 109) with videos related to

Pageof 11
Sort By:
Journal of Personalized Medicine|December 24, 2025
Pharmacoepigenomics in Personalized Medicine: A Hypothesis-Generating Approach to Introduce CpG-PGx SNPs as New Candidates for a Systematic Insight into Genomic-Epigenomic-Phenomic-Pharmacogenomics (G-E-Ph-PGx) AxisAlireza Sharafshah, Kenneth Blum, Kai-Uwe Lewandrowski, et al.
Psychology Research and Behavior Management|February 19, 2026
Beyond Stigma-Integrating Neurobiology, Genetics, and Awareness Integration Theory in Addiction RecoveryKenneth Blum, Mark S Gold, Nicole Jafari, et al.
Substance Use & Misuse|February 2, 2026
The Emerging Crisis in Non-Prescribed Ketamine Use: A Rapid Attenuation of Depression in Face of Abuse and "Chill-out" or Escapism DrugKai Uwe Lewandrowski, Kenneth Blum, Sergio Schmidt, et al.
Current Neuropharmacology|September 25, 2025
PGx-Based in silico Analyses Identifies the Interactive Role of Genes, Glucose Metabolism and Dopaminergic Dysfunctional Pathways with Chronic Cocaine use and MisuseAlireza Sharafshah, Panayotis K Thanos, Albert Pinhasov, et al.
Journal of Addiction Psychiatry|December 5, 2024
Theorizing that Psychedelic Assisted Therapy May Play a Role in the Treatment of Trauma-Induced Personality DisordersGianni Martire, Daniel Sipple, David Baron, et al.
Journal of Personalized Medicine|March 26, 2025
Genetic and Regulatory Mechanisms of Comorbidity of Anxiety, Depression and ADHD: A GWAS Meta-Meta-Analysis Through the Lens of a System Biological and Pharmacogenomic Perspective in 18.5 M SubjectsKai-Uwe Lewandrowski, Kenneth Blum, Alireza Sharafshah, et al.
Acta Scientific Neurology|June 10, 2026
Opioid-Induced Nodding-Not a Nice NapKenneth Blum, Alireza Sharafshah, Kyriaki Thanos, et al.
Neurology (E-Cronicon)|September 29, 2025
Multi-Locus Pro-Dopaminergic Restoration of Reward Brain Circuitry in Reward Deficiency Rescinds Mono-Pharmaceutical TargetingKenneth Blum, Kavya Mohankumar, Debasis Bagchi, et al.
Gene & Protein in Disease|August 1, 2025
Exploring dopamine as the master regulator of brain circuitry and mental health genomeKenneth Blum, Eric R Braverman, Alireza Sharafshah, et al.
Frontiers in Public Health|December 3, 2025
Correction: Targeting pro-dopaminergic agonism to attenuate depression in patients displaying genetic/epigenetic predisposition to hypodopaminergiaKai-Uwe Lewandrowski, Kenneth Blum, Alexander P L Lewandrowski, et al.
Pageof 11

Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
Journal of Personalized Medicine|December 24, 2025
Pharmacoepigenomics in Personalized Medicine: A Hypothesis-Generating Approach to Introduce CpG-PGx SNPs as New Candidates for a Systematic Insight into Genomic-Epigenomic-Phenomic-Pharmacogenomics (G-E-Ph-PGx) AxisAlireza Sharafshah, Kenneth Blum, Kai-Uwe Lewandrowski, et al.
Psychology Research and Behavior Management|February 19, 2026
Beyond Stigma-Integrating Neurobiology, Genetics, and Awareness Integration Theory in Addiction RecoveryKenneth Blum, Mark S Gold, Nicole Jafari, et al.
Substance Use & Misuse|February 2, 2026
The Emerging Crisis in Non-Prescribed Ketamine Use: A Rapid Attenuation of Depression in Face of Abuse and "Chill-out" or Escapism DrugKai Uwe Lewandrowski, Kenneth Blum, Sergio Schmidt, et al.
Current Neuropharmacology|September 25, 2025
PGx-Based in silico Analyses Identifies the Interactive Role of Genes, Glucose Metabolism and Dopaminergic Dysfunctional Pathways with Chronic Cocaine use and MisuseAlireza Sharafshah, Panayotis K Thanos, Albert Pinhasov, et al.
Journal of Addiction Psychiatry|December 5, 2024
Theorizing that Psychedelic Assisted Therapy May Play a Role in the Treatment of Trauma-Induced Personality DisordersGianni Martire, Daniel Sipple, David Baron, et al.
Journal of Personalized Medicine|March 26, 2025
Genetic and Regulatory Mechanisms of Comorbidity of Anxiety, Depression and ADHD: A GWAS Meta-Meta-Analysis Through the Lens of a System Biological and Pharmacogenomic Perspective in 18.5 M SubjectsKai-Uwe Lewandrowski, Kenneth Blum, Alireza Sharafshah, et al.
Acta Scientific Neurology|June 10, 2026
Opioid-Induced Nodding-Not a Nice NapKenneth Blum, Alireza Sharafshah, Kyriaki Thanos, et al.
Neurology (E-Cronicon)|September 29, 2025
Multi-Locus Pro-Dopaminergic Restoration of Reward Brain Circuitry in Reward Deficiency Rescinds Mono-Pharmaceutical TargetingKenneth Blum, Kavya Mohankumar, Debasis Bagchi, et al.
Gene & Protein in Disease|August 1, 2025
Exploring dopamine as the master regulator of brain circuitry and mental health genomeKenneth Blum, Eric R Braverman, Alireza Sharafshah, et al.
Frontiers in Public Health|December 3, 2025
Correction: Targeting pro-dopaminergic agonism to attenuate depression in patients displaying genetic/epigenetic predisposition to hypodopaminergiaKai-Uwe Lewandrowski, Kenneth Blum, Alexander P L Lewandrowski, et al.
Pageof 11